Govus Andrew D, Garvican-Lewis Laura A, Abbiss Chris R, Peeling Peter, Gore Christopher J
Centre for Exercise and Sports Science Research, School of Exercise and Health Science, Edith Cowan University, Joondalup, WA, Australia.
Department of Physiology, Australian Institute of Sport, Bruce, ACT, Australia; Research Institute for Sport and Exercise, University of Canberra, Bruce, ACT, Australia.
PLoS One. 2015 Aug 11;10(8):e0135120. doi: 10.1371/journal.pone.0135120. eCollection 2015.
To investigate the influence of daily oral iron supplementation on changes in hemoglobin mass (Hbmass) and iron parameters after 2-4 weeks of moderate altitude exposure.
Hematological data collected from 178 athletes (98 males, 80 females) exposed to moderate altitude (1,350-3,000 m) were analysed using linear regression to determine how altitude exposure combined with oral iron supplementation influenced Hbmass, total iron incorporation (TII) and blood iron parameters [ferritin and transferrin saturation (TSAT)].
Altitude exposure (mean ± s: 21 ± 3 days) increased Hbmass by 1.1% [-0.4, 2.6], 3.3% [1.7, 4.8], and 4.0% [2.0, 6.1] from pre-altitude levels in athletes who ingested nil, 105 mg and 210 mg respectively, of oral iron supplement daily. Serum ferritin levels decreased by -33.2% [-46.9, -15.9] and 13.8% [-32.2, 9.7] from pre-altitude levels in athletes who supplemented with nil and 105 mg of oral iron supplement daily, but increased by 36.8% [1.3, 84.8] in athletes supplemented with 210 mg of oral iron daily. Finally, athletes who ingested either 105 mg or 210 mg of oral iron supplement daily had a greater TII compared with non-supplemented athletes (0 versus 105 mg: effect size (d) = -1.88 [-2.56, -1.17]; 0 versus 210 mg: effect size (d) = -2.87 [-3.88, -1.66]).
Oral iron supplementation during 2-4 weeks of moderate altitude exposure may enhance Hbmass production and assist the maintenance of iron balance in some athletes with low pre-altitude iron stores.
研究在中度海拔暴露2 - 4周后,每日口服铁补充剂对血红蛋白量(Hbmass)变化及铁参数的影响。
对178名暴露于中度海拔(1350 - 3000米)的运动员(98名男性,80名女性)收集的血液学数据进行线性回归分析,以确定海拔暴露与口服铁补充剂如何共同影响Hbmass、总铁掺入量(TII)和血液铁参数[铁蛋白和转铁蛋白饱和度(TSAT)]。
海拔暴露(平均±标准差:21±3天)使每日分别摄入0毫克、105毫克和210毫克口服铁补充剂的运动员的Hbmass较海拔暴露前水平分别增加了1.1%[-0.4, 2.6]、3.3%[1.7, 4.8]和4.0%[2.0, 6.1]。每日补充0毫克和105毫克口服铁补充剂的运动员血清铁蛋白水平较海拔暴露前水平分别下降了-33.2%[-46.9, -15.9]和13.8%[-32.2, 9.7],但每日补充210毫克口服铁的运动员血清铁蛋白水平增加了36.8%[1.3, 84.8]。最后,每日摄入105毫克或210毫克口服铁补充剂的运动员的TII高于未补充的运动员(0毫克与105毫克相比:效应大小(d)=-1.88[-2.56, -1.17];0毫克与210毫克相比:效应大小(d)=-2.87[-3.88, -1.66])。
在中度海拔暴露2 - 4周期间口服铁补充剂可能会增强一些海拔暴露前铁储备较低的运动员的Hbmass生成,并有助于维持铁平衡。